Panacea has announced three senior appointments to support its expansion and growth plans.
Lynn Swain has been appointed as Client Manager and Qualified Person for Pharmacovigilance (QPPV). She has more than 20 years’ experience in the pharmacovigilance sector, her most recent role being at Lundbeck as Pharmacovigilance Manager for the UK and Ireland.
Panacea’s new Safety Scientist is Abbie Cooke who joins from Quinn Legal in the Isle of Man where she was a Compliance Officer.
Sue Feely has been appointed as Quality Administrator and joins from Zurich Bank International where she worked for 29 years.
Panacea Chairman, Stuart Colligon, welcomed the appointments and commented: “Panacea is passionate about delivering the highest quality service to our customers, and this has become one of our key attributes that appeals to the pharmaceutical industry. The collective experience, skills, and knowledge which Lynn, Abbie and Sue bring to our team will ensure that our quality levels remain consistently high as the company embarks on its next phase of expansion and growth.”
This latest announcement about recruitment follows the appointment earlier this year of Helen Lowe as Head of Quality. Helen has worked in the pharmaceutical industry for the majority of her career in both pharmacovigilance and auditing roles. Over the last ten years, during her time as an auditor, Helen has been involved with both pharmacovigilance systems and clinical trial sites. More recently, she has been a Qualified Person for Pharmacovigilance (QPPV) personally responsible for the safety of human pharmaceutical products in the EU and involved in audits and inspections from numerous regulatory authorities including the Medicines and Health Regulatory Agency (MHRA) and US Food and Drug Administration (FDA).
Panacea Pharma Projects has been trading since 2009 and is the only Isle of Man-based company specialising in pharmacovigilance. The company has 31 staff on-Island and four off-Island.